Project IntERact Study

Status Completed

Clinical Trial Summary

This study will use a randomized control trial design (RCT) to pilot test a multisession remote therapy behavioral intervention for risky firearm behaviors and associated behaviors/consequences among adolescents. The study will pilot a state-of-the-art intervention delivery approaches (e.g., remote therapy, smartphone-based APP intervention content delivery) for reducing violence and associated behaviors among urban youth. Given the significant morality and mortality associated with firearm violence, the study will have significant impact by identifying optimal intervention strategies for future large-scale behavioral intervention trials.

Clinical Trial Description

The specific aim of this pilot study is to pilot test an m-health intervention, as compared to enhanced usual care [n=70; 35/group], with eligible youth to assess intervention acceptability, feasibility, and fidelity, as well as trends towards decreased risky firearm behaviors, substance use, and criminal justice involvement. Specifically, 70 youth (ages 16-24) in the ED screening positive for firearm carriage and smartphone ownership will be randomly assigned (stratified by age/gender) to either the IntERact group or the control group. IntERact group participants will receive an Emergency Department (ED) session of behavioral therapy, followed by five additional remote therapy sessions of behavioral therapy delivered over the 5 weeks following their ED visit. Behavioral therapy will be comprised of motivational interviewing (MI), cognitive behavioral therapy (CBT), and strengths-based care management (CM). In addition, youth in the IntERact group will also receive a smartphone APP that will be downloaded to their phone. The APP will deliver daily surveys, daily tailored MI and CBT messages in response to survey results, one-touch access to pro-social supports, psycho-educational materials, GPS-enabled message alerts, and facilitated access to CM resources. Youth enrolled in the control group will receive a pamphlet with local violence, substance use, and mental health resources. A follow-up assessment will be completed in each group at 4 months post-ED visit. Pilot data will aid in refining and clarifying content and clinical trial design elements for a future fully powered randomized control trial of the intervention (i.e., R01 proposal). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03940716
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	N/A
Start date	May 27, 2020
Completion date	April 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06003725` - Cultural Adaptation of Drug Treatment for DJJ Youth	N/A
Recruiting	`NCT05414344` - A Brief Intervention for Alcohol Users With Interpersonal Trauma	N/A
Recruiting	`NCT05768815` - Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright	N/A
Completed	`NCT05606601` - An Online Intervention Addressing Mental Health and Substance Use in University Students	N/A
Completed	`NCT03489434` - Technology-Based Prevention for Adolescents in Primary Care	N/A
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Recruiting	`NCT05899101` - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed	`NCT02990026` - Specialty Mental Health Probation in North Carolina	N/A
Not yet recruiting	`NCT06116266` - Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)	N/A
Not yet recruiting	`NCT03249428` - E-Cigarette Inner City RCT	N/A
Active, not recruiting	`NCT03129334` - Preventing Prescription Drug Abuse in Middle School Students	N/A
Completed	`NCT04183400` - Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness	N/A
Completed	`NCT02112201` - The ProGirls Study	N/A
Completed	`NCT01752998` - Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings	N/A
Terminated	`NCT01661517` - Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting	Phase 0
Completed	`NCT01511380` - Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth	Phase 2
Completed	`NCT01351454` - Behavioral Depression Treatment for African American HIV-infected Substance Users	N/A
Completed	`NCT01154309` - Group CBT for Depression and AOD Disorders	Phase 1
Completed	`NCT01025674` - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8	N/A
Completed	`NCT00996541` - Support To Reunite Involve and Value Each Other	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.